SPERO THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Spero Therapeutics, Inc.
globenewswire.com
news
2022-05-31 20:15:00

LEAD PLAINTIFF DEADLINE IS JULY 25, 2022 NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed against Spero Therapeutics, Inc. ('Spero' or the Company') (NASDAQ: SPRO) in the United States District Court for the Eastern District of New York on behalf of a class consisting of those that purchased or otherwise acquired Spero securities between October 28, 2021 and May 2, 2022, All investors who purchased the shares of Spero Therapeutics, Inc.
